Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Processa Pharmaceuticals Inc. PCSA

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”

Posted on October 6, 2020 by MissionIR

Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process focuses on the advancement of … Continue reading →

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Pricing of $19.2M Public Offering, Nasdaq Uplisting

Posted on October 2, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, today announced the pricing of an underwritten public offering of 4,800,000 shares … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment